rhIGF

Related by string. * * rhIGF 1 . rhIGF-I/rhIGFBP-3 *

Related by context. All words. (Click for frequent words.) 66 somatostatin analogues 65 interferon alfa 2b 65 rhIGFBP 3 65 Leukine ® 65 CANCIDAS 64 interferon IFN 64 IFNs 64 visilizumab 64 decitabine 64 colorectal liver metastases 64 teriflunomide 63 IGFBP 3 63 luteinizing hormone releasing 63 Xanafide 63 IFN beta 63 antiarrhythmic drug 63 antithrombotics 63 daunorubicin 63 cinacalcet 63 MGd 63 binding protein IGFBP 63 IGFBP 63 antitumor effect 63 idraparinux 62 somatostatin 62 tocilizumab 62 TNF α 62 rhGH 62 vildagliptin 62 CIMZIA ™ 62 receptor inhibitor 62 AGHD 62 tacrolimus ointment 62 sargramostim 62 TriRima 62 plasminogen activators 62 titrated glipizide 62 receptor subtypes 62 Estradiol 62 CHOP chemotherapy 62 5alpha reductase 62 pomalidomide 62 FXIII 62 idarubicin 62 isoproterenol 62 antiarrhythmic 62 salmeterol fluticasone 62 NPH insulin 62 antiangiogenic therapy 62 IFN α 62 octreotide LAR 62 mycophenolate mofetil 62 sorafenib Nexavar 61 azacitidine 61 Traficet EN 61 thymalfasin 61 #HT#A 61 Protelos 61 pro angiogenic 61 FOSRENOL ® 61 angiotensin receptor blocker ARB 61 TNFalpha 61 zoledronate 61 HeFH 61 LEUKINE 61 selective modulator 61 PTHrP 61 VEGF inhibitors 61 hyperoxaluria 61 aspirin clopidogrel 61 bendamustine 61 TNF antagonist 61 5 HT2C receptor 61 apolipoproteins 61 tigecycline 61 steroid dexamethasone 61 N methyl 61 T2DM 61 LTB4 61 erythropoietic 61 Interferon alfa 61 antiepileptics 61 Platinol 61 lipoic acid 61 Interferon beta 61 heparins 61 SSRI citalopram 61 azelaic acid 61 somatostatin analog 61 olmesartan 61 prucalopride 61 BENICAR HCT 61 platelet inhibitor 61 paricalcitol 61 Fc receptor 61 proteoglycan 61 5HT 61 INCB# [003] 61 APTIVUS 61 somatostatin analogs 61 Symadex 61 macroalbuminuria 61 lanreotide 61 neurotrophic 61 colony stimulating factor 61 metformin sulfonylurea 61 erlotinib Tarceva ® 61 dosage regimens 61 receptor blocker 61 pharmacokinetic interactions 61 pramlintide metreleptin combination 61 selective adenosine 61 5-FU/LV 61 activin 61 relapsed MM 60 Vidofludimus 60 fluticasone salmeterol 60 pimecrolimus cream 60 methotrexate monotherapy 60 antiapoptotic 60 fluoropyrimidine 60 caspofungin 60 subcutaneously administered 60 effector function 60 TGF ß 60 antiandrogens 60 riociguat 60 GnRH agonist 60 pharmacodynamic PD 60 prostaglandin E 60 tricyclic antidepressant 60 noninfectious uveitis 60 Glucocorticoids 60 JAK inhibitors 60 pharmacologically active isomer 60 canakinumab 60 receptor tyrosine kinase inhibitor 60 serum phosphate levels 60 INVEGA ® 60 coadministration 60 lymphocyte activation 60 hypoxia inducible factor 60 mTOR inhibitors 60 EFFEXOR XR 60 certolizumab 60 somatostatin analogue 60 AEGR 60 thiazide diuretic 60 oxcarbazepine 60 VAPRISOL 60 Zavesca R 60 inotropic 60 β blockers 60 fosbretabulin 60 overt nephropathy 60 subclinical hypothyroidism 60 fibrotic disease 60 antidiabetic 60 hormone LHRH 60 PPAR gamma agonists 60 insulin lispro 60 immune modulator 60 HMG CoA reductase inhibitors 60 anti fibrotic 60 insulin sensitizers 60 docetaxel chemotherapy 60 azacytidine 60 benign prostatic hypertrophy BPH 60 systemic bioavailability 60 IL 1ß 60 YONDELIS 60 trans retinoic acid 60 direct thrombin inhibitors 60 systemic corticosteroid 60 ibandronate 60 partial agonist 60 mTOR mammalian target 60 acne vulgaris 60 ara C 60 busulfan 60 imipenem 60 bexarotene 60 plasma lipid 60 GAMMAGARD 60 immune modulating 60 cardiac toxicity 60 antioxidant supplementation 60 adalimumab 60 Etanercept 60 Oral NKTR 60 prostanoid 60 immunoregulatory 60 DMARDS 60 GHRH 60 Anticalins ® 60 secondary hyperparathyroidism 60 gefitinib Iressa 60 Doxil ® 60 pramlintide 60 antiemetics 60 Degarelix 60 vorinostat 60 ACZ# 60 micafungin 60 ZOLINZA 60 L carnitine 60 macrophage colony stimulating 60 antidepressants SSRIs 60 HT 1A 60 teriparatide 60 Akt activation 59 adriamycin 59 favorable pharmacokinetic profile 59 EGFR tyrosine kinase inhibitors 59 prostaglandin analogues 59 liposomal doxorubicin 59 myeloproliferative diseases 59 cobalamin 59 angiotensin converting enzyme inhibitors 59 androgen independent 59 Peg IFN 59 lipid lowering agents 59 DFMO 59 HT 2A 59 vasodilatory 59 SERMs 59 ENMD # 59 vidofludimus 59 intravesical therapy 59 postprandial glycemia 59 bone morphogenetic protein 59 ULORIC 59 59 docetaxel Taxotere ® 59 insulin analogs 59 PRTX 59 Aurora kinase 59 sodium glucose cotransporter 59 cardioprotection 59 hepatic encephalopathy 59 beta 1a 59 thyrotropin 59 Recombinant Human 59 mixed hyperlipidemia 59 flutamide 59 Dasatinib 59 #ME# 59 xenograft models 59 hematologic toxicity 59 interferon alfa 59 serum phosphate 59 viral kinetics 59 LHRH agonists 59 tiotropium bromide 59 eNOS 59 VEGF receptor 59 exendin 4 59 anti leukemic 59 gadobutrol 59 μmol L 59 sevelamer 59 isoenzyme 59 LHRH antagonists 59 symptomatic paroxysmal AF 59 ubiquinol 59 CYP#D# 59 ACTEMRA TM 59 Th2 cytokines 59 calcitriol 59 ziprasidone 59 receptor subtype 59 amphotericin B 59 T#I [002] 59 6R BH4 59 fenretinide 59 bicalutamide 59 HPA axis 59 TREANDA 59 alpha lipoic acid 59 bosentan 59 invasive candidiasis 59 coronary stenosis 59 low dose cytarabine 59 Adenosine 59 calcineurin inhibitors 59 PDGFR 59 t# c# CLA 59 immunostimulatory 59 IFN γ 59 enzastaurin 59 EGFr 59 thromboembolic complications 59 glutamyl 59 lupus nephritis 59 betamethasone dipropionate 59 SERCA2a 59 insulin sensitizing 59 Severe Primary IGFD 59 HuMax EGFr 59 etoposide 59 hypoparathyroidism 59 glitazones 59 glulisine 59 Privigen 59 serum concentrations 59 oral antidiabetic 59 CYP #A# 59 antidepressant efficacy 59 SAMe 59 zonisamide SR 59 risperidone Risperdal 59 hepatoma 59 antiplatelet agents 59 xanthine oxidase inhibitor 59 pharmacokinetic PK profile 59 CD1d 59 STAT3 activation 59 analgesic efficacy 59 SGLT2 inhibitors 59 thiopurine 59 PDGF receptor 59 TGF β 59 serum calcium levels 59 long acting bronchodilator 59 FOCALIN XR 59 stavudine d4T 59 Insulin detemir 59 macrolide antibiotics 59 tumorigenicity 59 gp# vaccine 59 uric acid lowering 59 Lubiprostone 59 selective inhibition 59 primary hypercholesterolemia 59 IgG1 59 antiinflammatory 59 alpha2 59 CTAP# Capsules 59 isoenzymes 59 octreotide acetate 59 antithrombotic 59 dopamine partial agonist 59 Fas ligand 59 carcinoid tumors 59 biologic DMARD 59 divalproex sodium 59 growth hormone secretion 58 Elitek 58 CIMZIA TM 58 TGF beta1 58 breast cancer subtypes 58 nab paclitaxel 58 orally bioavailable mimics 58 dexamethasone Decadron 58 basic fibroblast 58 K ras mutations 58 ergocalciferol 58 Tubulin 58 IFN gamma 58 HepG2 cells 58 quinolone 58 methotrexate therapy 58 TGFß 58 systemic lupus erythematosus SLE 58 fulvestrant 58 PXD# 58 Zevalin consolidation 58 vWF 58 nicotinic receptor 58 HIV HCV coinfected 58 diarrhea predominant irritable 58 microglial activation 58 HMG CoA reductase inhibitor 58 metaglidasen 58 lactulose 58 CsA 58 gonadotropins 58 NK1 58 typical antipsychotics 58 MEVACOR 58 eprotirome 58 glucosamine hydrochloride 58 FOLFOX4 58 atherogenic dyslipidemia 58 acarbose 58 APTIVUS r 58 MEK1 58 posaconazole 58 Telintra 58 interleukin IL -# 58 anticonvulsants 58 LB# [003] 58 liver histology 58 Panzem R 58 Lovaza ® 58 INTEGRILIN 58 CGRP 58 CD4 + CD# 58 MAGE A3 ASCI 58 epigenetic therapies 58 tumor xenograft models 58 pegylated IFN 58 schizophrenia CIAS 58 BAY #-# 58 adrenal suppression 58 Targretin 58 ZFP TF 58 milatuzumab 58 glargine 58 heparanase 58 oral prodrug 58 FGF2 58 efalizumab 58 TIMP 1 58 vinca alkaloid 58 c MET 58 GH deficiency 58 cell lymphoma CTCL 58 antihypertensive therapy 58 Imprime PGG 58 metastatic neuroendocrine tumors 58 urocortin 2 58 TNFa 58 liposomal formulation 58 mRNA expression 58 HuLuc# 58 serum TSH 58 imipramine 58 serum IGF 58 Ziprasidone 58 opioid receptor antagonist 58 Eligen R B# 58 quetiapine Seroquel 58 intravenous bisphosphonates 58 protease inhibitor PI 58 corticosteroid dose 58 guanfacine extended release 58 capsular polysaccharide 58 water soluble vitamin 58 Lenalidomide 58 adjunctive ABILIFY 58 ursodeoxycholic acid 58 carvedilol 58 ziconotide 58 biologic plausibility 58 hepatocellular 58 IOP lowering 58 clomipramine 58 deferiprone 58 Tasimelteon 58 SCIg 58 5 hydroxytryptamine 58 rHuPH# 58 dose interleukin 58 imatinib resistant 58 steroidogenic 58 SGLT1 58 itraconazole 58 pharmacodynamic profile 58 cytokine IL 58 brivaracetam 58 ALGRX 58 myelofibrosis polycythemia vera 58 colorectal adenoma 58 anti angiogenic agents 58 piperacillin tazobactam 58 glucocorticoid 58 Kahalalide F 58 CLA isomers 58 Nilotinib 58 serum LDL cholesterol 58 TYGACIL 58 Abilify aripiprazole 58 intravenous cyclophosphamide 58 antitumor efficacy 58 #F FDG PET 58 ALT elevations 58 plus medroxyprogesterone acetate 58 serotonin synthesis 58 C1 INH 58 EGFR inhibitors 58 IGF IR 58 linear pharmacokinetics 58 ERBB2 58 pitavastatin 58 Leukine 58 citalopram 58 menadione 58 Bortezomib 58 LT NS# 58 GPx 58 adrenocortical 58 subcutaneously injected 58 HER2 expression 58 CEACAM1 58 PI3K inhibitors 58 improves glycemic 58 antidiabetic drugs 58 triglyceride lowering 58 etanercept 58 interpersonal psychotherapy 58 Focalin XR 58 Inhalation Solution 58 NO synthase 58 mineralocorticoid 58 plasma leptin 58 metaplasia 58 Teriflunomide 58 TREDAPTIVE 58 JAK inhibitor 58 Pertuzumab 58 aripiprazole 58 lysosomal enzyme iduronate 58 GMX# 58 ascending dose 58 donepezil Aricept 58 dyslipidaemia 58 PKC# 58 Vaprisol 58 cyclosporin 58 CYT# potent vascular disrupting 58 INC# 58 adjunctive placebo 58 SGPT 58 NN# [001] 58 tumor antigen 58 hypertonic saline 58 prognostic significance 58 parathyroid hormone PTH 58 Gleevec resistant 58 clozapine 58 clobazam 58 bezafibrate 58 Tyrima 57 GSTP1 57 nucleotide analogs 57 DOXIL 57 serum urate levels 57 basal bolus regimen 57 chemotherapeutic drug 57 interferon α 57 receptor agonists 57 Omacetaxine mepesuccinate 57 ARB telmisartan 57 demonstrated antitumor activity 57 tricyclic 57 nucleoside analogues 57 serotonin receptor 57 kallikrein 57 uM 57 antiangiogenic 57 FLT3 57 rFVIIa 57 papillary renal cell carcinoma 57 ERK1 2 57 cardioprotective effects 57 TNF Tumor Necrosis Factor 57 Angiotensin Converting Enzyme 57 tolvaptan 57 selective agonist 57 neurite outgrowth 57 Genz # 57 Bezielle 57 MTP inhibitor 57 abacavir lamivudine 57 ubiquinone 57 Teriparatide 57 Galantamine 57 FasL 57 liposomal amphotericin B 57 insulin detemir 57 Pioglitazone 57 cMET 57 IFN alpha 57 histological subtype 57 A1PI 57 haematopoietic 57 Perforomist Inhalation Solution 57 lipid lowering therapy 57 vanilloid receptor 57 AGILECT R 57 epithelial tumors 57 hypericin 57 transgene expression 57 Interferon alpha 57 gliclazide 57 conventional antipsychotics 57 GAMMAGARD LIQUID 57 IL6 57 interleukin IL 57 #beta estradiol 57 GM CSF granulocyte 57 retinoid 57 Hizentra 57 colesevelam HCl 57 dimeglumine 57 platelet reactivity 57 factor HGF 57 coenzyme 57 antimetabolite 57 nonalcoholic steatohepatitis NASH 57 biliary tract cancer 57 anti inflammatory cytokine 57 oral diclofenac 57 peginterferon 57 MnSOD 57 beta adrenergic 57 IL 1beta 57 Granulocyte Colony Stimulating Factor 57 EBRT 57 pro inflammatory cytokine 57 reslizumab 57 fluvastatin 57 CYP #D# 57 proinflammatory cytokine 57 histone deacetylase inhibitor 57 antithrombotic agents 57 superoxide dismutase 57 meropenem 57 IL #p# 57 Dapagliflozin 57 orally administered inhibitor 57 lamotrigine 57 mirtazapine 57 incretin 57 uricase 57 Targretin capsules 57 mg BID dose 57 TORISEL 57 alkylating agent 57 protein tyrosine phosphatases 57 essential thrombocythemia 57 SNRI 57 airway hyper responsiveness 57 juvenile idiopathic arthritis 57 tipranavir 57 cytokine interleukin 57 oral antidiabetic medication 57 TNF alpha antagonist 57 CaPre TM 57 paclitaxel Taxol 57 Primary IGFD 57 neuroleptic 57 REMINYL ® 57 phosphate binders 57 biologic therapy 57 cytotoxicity assays 57 tranylcypromine 57 gastric adenocarcinoma 57 PON1 enzyme 57 VEGFR1 57 prostate cancer PCa 57 ALB # 57 D aspartate NMDA receptor 57 MP4OX 57 NeuroSTAT ® 57 GFT# 57 sitosterol 57 intravenously administered 57 CYP#A# CYP#D# 57 BENICAR 57 related apoptosis inducing 57 hypercalcemia 57 urinary N telopeptide 57 BoNT 57 ACh 57 chronic periodontitis 57 L arginine 57 spermidine 57 PNH patients 57 pDC 57 serum PTH 57 apolipoprotein AI 57 pegylated 57 forskolin 57 Effexor venlafaxine 57 vasoactive 57 dose proportionality 57 chlorambucil 57 deoxy 57 PPARγ 57 refractory AML 57 diabetic gastroparesis 57 pharmacodynamics PD 57 IFN ß 57 metabolic parameters 57 SCH # 57 raltegravir 57 platelet inhibition 57 glucocorticoids 57 interferon alpha 57 immunofluorescence staining 57 NATRECOR ® 57 selective inhibitor 57 surrogate endpoint 57 hepatic metastases 57 oral rivaroxaban 57 serous ovarian cancer 57 fumarate 57 glycosylated 57 immunomodulatory effects 57 paroxetine Paxil 57 pioglitazone HCl 57 Moxifloxacin 57 clozapine Clozaril 57 inhibit COX 57 alvespimycin 57 Taxol ® 57 Resten NG 57 triacylglycerol 57 substrate specificity 57 antitumor effects 57 OPAXIO 57 Study GL# 57 urothelial carcinoma 57 gastric carcinoma 57 pharmacodynamic properties 57 Sjögren syndrome 57 Lamotrigine 57 hypercholesterolemia 57 PRADAXA 57 chronic lymphocytic leukemia CLL 57 Rebif ® 57 lipid abnormalities 57 microtubule targeting 57 active comparator 57 ABCB1 57 airway hyperresponsiveness 57 Fenretinide 57 HER2 overexpression 57 Angiotensin converting enzyme 57 fallopian tube cancers 57 Adalimumab 57 Nampt 57 thrombopoietin 57 maximally tolerated dose 57 double blinded placebo 57 plus dexamethasone 57 acetonide FA 57 inhaled corticosteroid therapy 57 osteoblast 57 BeneFIX 57 mixed dyslipidemia 57 leukemia AML 57 PRECiSE 57 Maribavir 57 bone morphogenic protein 57 IV bisphosphonates 57 receptor blockers 57 haematologic 57 interferon beta 1b 57 gemifloxacin 57 hepatic encephalopathy HE 57 castrate resistant prostate cancer 57 CYT# QbG# 57 5 lipoxygenase 57 forodesine 57 benzothiazole 57 synthetic retinoid 57 AGILECT ® 57 Fc gamma receptor 57 5 Fluorouracil 57 tubulin inhibitor 57 ZOMIG Nasal Spray 57 goserelin 57 SinuNase 57 interleukins 57 cyclooxygenase 2 57 pyridostigmine 57 Th2 responses 57 Cloretazine 57 dyslipidemias 57 synthetic siRNA 57 EGb 57 anxiolytic 57 fenofibric acid 57 Vidaza ® 57 lactate dehydrogenase LDH 57 #mg doses [002] 57 Azedra 57 miglustat 57 benign neoplasms 57 haloperidol Haldol 57 glutathione peroxidase 57 heavily pretreated 57 enterolactone 57 5 HT1A 57 PEDF 57 flavopiridol 57 atypical hemolytic uremic syndrome 57 hormone LHRH antagonist 57 PDE4 inhibitor 57 bleomycin 57 Poly ICLC 57 extrapyramidal symptoms 57 cyclin dependent kinases 57 ziprasidone Geodon 57 NATRECOR R 57 NR2B selective 57 relapsed SCLC 57 antiandrogen 57 atypical antipsychotic medications 57 tumor histology 57 ceftazidime 57 Omacetaxine 57 adrenergic receptors 57 intracranial hemorrhage ICH 57 olanzapine Zyprexa 57 CIMZIA TM certolizumab pegol 57 estrone 57 topical formulations 57 left ventricular systolic 57 mecamylamine 57 EXJADE 57 small molecule activators 57 ganciclovir 57 cyclin dependent kinase inhibitor 56 KRAS status 56 TELINTRA 56 dyslipidemia 56 MNTX 56 postprandial glucose 56 HSCT 56 desvenlafaxine succinate 56 clinicopathological 56 juvenile idiopathic arthritis JIA 56 cytokine signaling 56 Vascular endothelial growth 56 mutational status 56 insulin sensitization 56 antiproliferative effects 56 PDE#A 56 Helicobacter pylori eradication 56 acromegalic patients 56 ligand TRAIL 56 Copegus ribavirin 56 nonsmall cell lung cancer 56 Kinoid 56 gastrin 56 postoperative AF 56 mRCC 56 constipation predominant irritable bowel 56 RoACTEMRA 56 lipoxygenase 56 deferoxamine 56 Calcitonin 56 JVRS 56 AtherOx 56 symptomatic VTE 56 oncologic outcomes 56 renal toxicity 56 bortezomib Velcade 56 5 HT2A 56 lipid lowering therapies 56 neovascularization 56 histologies 56 DMARD 56 PSADT 56 poor metabolizers 56 Th1 56 B7 H3 56 pouchitis 56 pheochromocytoma 56 galectin 56 microtubule inhibitor 56 ancrod 56 immunomodulatory therapy 56 FOSRENOL R 56 tiotropium 56 daptomycin 56 bronchodilation 56 IGIV 56 immune modulatory 56 antidiabetic medications 56 anticonvulsant 56 conventional DMARDs 56 muscarinic antagonist 56 CoFactor 56 microdose 56 peptide antigens 56 trabectedin 56 MTHFR 56 metformin monotherapy 56 AZT zidovudine Retrovir 56 ERalpha 56 EGFR HER2 56 interferon γ 56 fondaparinux 56 dasatinib Sprycel 56 R baclofen 56 hyperinsulinemic euglycemic clamp 56 hexose 56 N acetylcysteine 56 Leydig cell 56 veltuzumab 56 aripiprazole Abilify 56 indinavir 56 muscarinic 56 elastase 56 plasma folate 56 nephrotoxicity 56 PI3K Akt 56 sipuleucel T 56 PREZISTA r 56 hypercholesterolaemia 56 sulodexide 56 1 receptor IGF 56 venlafaxine Effexor 56 Dextofisopam 56 Aquamid 56 equol 56 osteogenic 56 desmopressin 56 pegylated interferons 56 vWD 56 adipogenic 56 VA# [002] 56 capsule formulation 56 immunomodulation 56 placebo controlled studies 56 ZYVOX 56 prescribed proton pump 56 agonism 56 moderate renal impairment 56 prostate carcinoma 56 indomethacin 56 cystatin 56 phosphodiesterase inhibitors 56 follicular lymphomas 56 HoFH 56 antiangiogenic agents 56 metastatic lymph nodes 56 glucose lowering 56 IgG4 56 atypical antipsychotic 56 radezolid 56 pegfilgrastim 56 #mg/day [001] 56 HGPIN 56 memantine Namenda 56 ovarian carcinoma 56 HCV SPRINT 56 #F FDG 56 dosing frequency 56 cAMP signaling 56 HIF 1a 56 HER2 positive metastatic breast 56 SPRIX ® 56 oral Xeloda 56 effector memory 56 nucleotide analogues 56 refractory gout 56 human microdosing 56 alicaforsen enema 56 KAPIDEX 56 lipid lowering 56 serum leptin 56 ONGLYZA saxagliptin 56 eosinophilic asthma 56 severe Primary IGFD 56 chemoradiotherapy 56 novel histone deacetylase 56 renal tumors 56 Plicera 56 antisense compounds 56 LDL cholesterol lowering 56 eszopiclone 56 glycoprotein IIb IIIa inhibitors 56 atypical neuroleptics 56 recurrent glioblastoma multiforme 56 lispro 56 immunomodulating 56 histologic subtype 56 DAVANAT 56 plasma kallikrein 56 alkylating 56 peptide YY 56 overactive bladder syndrome 56 grade cervical intraepithelial 56 #.#mg dose 56 Aptivus ® 56 adecatumumab 56 apoA 56 EVIZON 56 glycated hemoglobin levels 56 pyrimidines 56 follicular lymphoma FL 56 granisetron 56 #mg dose [001] 56 somatostatin receptor 56 agomelatine 56 ADAM# 56 diabetes mellitus T2DM 56 pharmacokinetic characteristics 56 CDK inhibitor 56 N acetyl 56 apolipoprotein B 56 cytoreductive nephrectomy 56 LY# [003]

Back to home page